Subscribe
Logo small
Search

ABM to fund study on arrhythmogenic right ventricular cardiomyopathy

MedExpress Team

Medexpress

Published April 17, 2023 09:06

ABM to fund study on arrhythmogenic right ventricular cardiomyopathy - Header image
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease that most often manifests in young, apparently healthy adults. It is the most common cause of sudden death in athletes in Europe. Researchers at the National Institute of Cardiology are looking for a way to prevent the progression of the disease.

From April 17 to 24, we are celebrating Heart Week. Cardiovascular diseases pose the greatest challenge to modern medicine, especially since young people are increasingly affected.

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare heart disease characterized by progressive replacement of the heart muscle with fatty or fibrous tissue. This results in cardiac arrhythmias that can be life-threatening especially in young people. ARVC is genetically determined. The disease can have a variety of symptoms, most commonly manifested by palpitations and loss of consciousness during exertion, often in a person unaware of his disease. In later stages of the...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Topics

kardiomiopatia / ABM

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Najciekawsze oferty pracy (przewiń)

Read also